These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23872728)

  • 1. Use of mastoid obliteration techniques in cholesteatoma.
    Yung M; Bennett A
    Curr Opin Otolaryngol Head Neck Surg; 2013 Oct; 21(5):455-60. PubMed ID: 23872728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow up after bony mastoid and epitympanic obliteration: radiological findings.
    Vercruysse JP; De Foer B; Somers T; Casselman J; Offeciers E
    J Laryngol Otol; 2010 Jan; 124(1):37-43. PubMed ID: 19775491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Results of Troublesome CWD Cavity Reconstruction by Mastoid and Epitympanic Bony Obliteration (CWR-BOT) in Adults.
    Vercruysse JP; van Dinther JJ; De Foer B; Casselman J; Somers T; Zarowski A; Cremers CC; Offeciers E
    Otol Neurotol; 2016 Jul; 37(6):698-703. PubMed ID: 27023012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
    Kim CW; Oh JI; Choi KY; Park SM; Park MI
    Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canal wall-down mastoidectomy with mastoid obliteration for pediatric cholesteatoma.
    Sun J; Sun J; Hu Y; Lv Q; Wang Y; Li X; Xu W; Wang S; Mei Z; Wan G
    Acta Otolaryngol; 2010 Feb; 130(2):259-62. PubMed ID: 19565369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canal wall up surgery with mastoid and epitympanic obliteration in acquired cholesteatoma.
    Hellingman CA; Geerse S; de Wolf MJF; Ebbens FA; van Spronsen E
    Laryngoscope; 2019 Apr; 129(4):981-985. PubMed ID: 30408197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastoid and epitympanic bony obliteration in pediatric cholesteatoma.
    Vercruysse JP; De Foer B; Somers T; Casselman JW; Offeciers E
    Otol Neurotol; 2008 Oct; 29(7):953-60. PubMed ID: 18719515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-EPI DW MRI in planning the surgical approach to primary and recurrent cholesteatoma.
    Migirov L; Wolf M; Greenberg G; Eyal A
    Otol Neurotol; 2014 Jan; 35(1):121-5. PubMed ID: 24317217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results.
    Al Tamami N; Bawazeer N; Fieux M; Zaouche S; Tringali S
    Am J Otolaryngol; 2020; 41(6):102542. PubMed ID: 32620365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful obliteration of troublesome and chronically draining cavities.
    Geerse S; Ebbens FA; de Wolf MJ; van Spronsen E
    J Laryngol Otol; 2017 Feb; 131(2):138-143. PubMed ID: 28069077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of cholesteatoma: status of the canal wall.
    Syms MJ; Luxford WM
    Laryngoscope; 2003 Mar; 113(3):443-8. PubMed ID: 12616194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mastoid obliteration: autogenous cranial bone pAte reconstruction.
    Roberson JB; Mason TP; Stidham KR
    Otol Neurotol; 2003 Mar; 24(2):132-40. PubMed ID: 12621322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative to canal wall-down mastoidectomy for sclerotic mastoid cavities: epitympanoplasty with mastoid obliteration.
    Heo KW; Kang MK; Park JY
    Ann Otol Rhinol Laryngol; 2014 Jan; 123(1):47-52. PubMed ID: 24574423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial mastoid obliteration combined with soft-wall reconstruction for middle ear cholesteatoma.
    Suzuki H; Ikezaki S; Imazato K; Koizumi H; Ohbuchi T; Hohchi N; Hashida K
    Ann Otol Rhinol Laryngol; 2014 Aug; 123(8):571-5. PubMed ID: 24634153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic Management of Primary Acquired Cholesteatoma.
    Chiao W; Chieffe D; Fina M
    Otolaryngol Clin North Am; 2021 Feb; 54(1):129-145. PubMed ID: 33131767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of high-resolution computed tomography and magnetic resonance imaging in the detection of residual cholesteatomas in primary bony obliterated mastoids.
    De Foer B; Vercruysse JP; Pouillon M; Somers T; Casselman JW; Offeciers E
    Am J Otolaryngol; 2007; 28(4):230-4. PubMed ID: 17606036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which technique is better for cholesteatoma surgery?
    Deniz M; Uslu C; Koldaş C; Deniz B
    B-ENT; 2015; 11(2):109-15. PubMed ID: 26563010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canal wall reconstruction in cholesteatoma surgeries: rate of residual.
    Roux A; Bakhos D; Lescanne E; Cottier JP; Robier A
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2791-7. PubMed ID: 25227760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastoid obliteration with hydroxyapatite--the value of high resolution CT scanning in detecting recurrent cholesteatoma.
    Yung MM; Karia KR
    Clin Otolaryngol Allied Sci; 1997 Dec; 22(6):553-7. PubMed ID: 9466070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canal wall reconstruction tympanomastoidectomy with mastoid obliteration.
    Gantz BJ; Wilkinson EP; Hansen MR
    Laryngoscope; 2005 Oct; 115(10):1734-40. PubMed ID: 16222186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.